We are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. We designed our first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, to help patients with Type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals. V-Go is indicated for continuous subcutaneous infusion of insulin over 24 hours at preset rates and on-demand bolus dosing in two-unit increments in adult patients requiring insulin. V-Go is a small, discreet and easy-to-use disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. V-Go enables patients to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. V-Go enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin (fast-acting) at a continuous preset (background) basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. In numerous real-world analyses V-Go has consistently shown to lower A1C’s with less insulin. The discreet and convenient basal-bolus insulin delivery method provided by V-Go empowers patients to simplify their insulin management thereby mitigating the need to plan their daily routine around multiple daily injections. V-Go is cleared for use in the United States and the E.U. is commercially available in the United States.
View Top Employees from ValeritasWebsite | http://www.valeritas.com |
Ticker | VLRX |
Revenue | $26 million |
Funding | $245 million |
Employees | 57 (57 on RocketReach) |
Founded | 2006 |
Address | 750 Route 202 South, Bridgewater, New Jersey 08807, US |
Phone | (908) 927-9920 |
Fax | (908) 927-9927 |
Technologies |
JavaScript,
HTML,
Twitter
+18 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Brokerage, Biotechnology, Finance, Science and Engineering, Banking, Diabetes, Investment Banking, Health Care, Medical Device |
Web Rank | 2 Million |
Keywords | Valeritas, Valeritas Holdings, Vgo Inc Careerw, Valeritas Earnings, Vlaritas Diabetes |
Competitors | Animas Corporation, CeQur, Depomed, Inc., Insulet Corporation, Intarcia Therapeutics, Inc. |
SIC | SIC Code 621 Companies, SIC Code 62 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Valeritas employee's phone or email?
The Valeritas annual revenue was $26 million in 2024.
Erick Lucera is the CFO of Valeritas.
57 people are employed at Valeritas.
Valeritas is based in Bridgewater, New Jersey.
The NAICS codes for Valeritas are [325, 32, 32541, 3254].
The SIC codes for Valeritas are [621, 62].